🟢 HELP is trading 9.1% up today after pricing a $50M public offering

HELP is trading 9.1% up at $5.29 in pre-market action after announcing a $50 million underwritten public offering priced at $4.85 per share.

• The financing strengthens Helus Pharma’s balance sheet and provides dedicated funding for the Phase 3 development of HLP003 for major depressive disorder.
• Proceeds will also support additional pipeline programs, which investors view as a key step in reducing funding risk and securing long-term clinical progress.